Skip to content

Shedding light on brain oxygenation

Multiple Sclerosis | Fatigue | Brain | Fatigue and Tiredness

Our research group, led by Dr. Jeff Dunn, has identified low oxygen levels – a condition known as hypoxia, in the brain of 33% of people with Multiple Sclerosis (MS). We are currently conducting a research study to explore how hypoxia relates to symptoms, brain function, and progression.

We apply safe, non-invasive techniques, including near-infrared spectroscopy (NIRS) and electroencephalography (EEG), to measure brain oxygen levels and function. We also conduct MRI scans and collect a blood sample to identify physiological markers, such as inflammation, changes in brain structure and blood flow, and disease progression, as indicated by lesion load and brain atrophy.
All techniques used in our study are safe. Participants may choose to take part in one or more components of the study.

By comparing results from healthy participants and participants with MS, we aim to better understand how changes in brain oxygen and physiology may be linked to brain function and disease progression.

If you are interested in learning more, please fill out the short form below. Our research team will contact you to discuss the study and review eligibility criteria.

null

Conditions de participation

  • Sexe:

    Male, Female, Intersex

  • Âges admissibles:

    18 to 75

Critères de participation

Inclusion Criteria:
Age 18-75
Men and women
Clinical diagnosis of MS
Non-smoker (Nicotine or Marijuana)

Selection criteria - Healthy Participants:
Age 18-75
Men and women
Non-smoker (Nicotine or Marijuana)
No recent systemic infection
Otherwise healthy
No history of cardiovascular/vascular disease

Lieu de l'étude

University of Calgary
University of Calgary
Calgary, Alberta
Canada

Contactez l'équipe d'étude

Étude parrainée par
University of Calgary
Participants recherchés
Plus d'informations
ID de l'étude: REB19-1105